Reduction of Plasma BCAAs following Roux-en-Y Gastric Bypass Surgery Is Primarily Mediated by FGF21

Reduction of Plasma BCAAs following Roux-en-Y Gastric Bypass Surgery Is Primarily Mediated by FGF21

Type 2 diabetes (T2D) is a challenging health concern worldwide. A lifestyle intervention to treat T2D is difficult to adhere, and the effectiveness of approved medications such as metformin, thiazolidinediones (TZDs), and sulfonylureas are suboptimal. On the other hand, bariatric procedures such as...

Full description

Bibliographic Details
Main Authors: Harsh Shah, Alyssa Kramer, Caitlyn A. Mullins, Marie Mattern, Ritchel B. Gannaban, R. Leigh Townsend, Shawn R. Campagna, Christopher D. Morrison, Hans-Rudolf Berthoud, Andrew C. Shin
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Nutrients
Subjects:
RYGB
branched-chain amino acids
GLP-1
PYY
glycemic control
Online Access:https://www.mdpi.com/2072-6643/15/7/1713

Internet

https://www.mdpi.com/2072-6643/15/7/1713

Similar Items